Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Stroke 1Neoplasms 1Hypotension 1Brain Neoplasms 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Phenylephrine × Clear all
NCT06711432 2024-12-02

PRECISION

Zhejiang Cancer Hospital

Phase NA Recruiting
214 enrolled

Neoplasms, Stroke

NCT02713087 2018-10-26

Vasopressor Effects in Anesthetized Patients

University of Aarhus

Phase 4 Completed
48 enrolled
CNS

Brain Neoplasms

NCT03215797 2018-01-23

Phenylephrine or Norepinephrine for a Better Hemodynamic Stability

The Second Affiliated Hospital of Dalian Medical University

Phase 3 Completed
40 enrolled

Hypotension

Data powered by HemOnc (CC BY 4.0) Colophon âš¡